Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trialRoger Li, Gary D. Steinberg, Tyler F. Stewart et al.|Nature Medicine|2024Cited by 64